Five Deans Technology Showcases E-Cigarette Products at Dortmund Tobacco Exhibition

Sep.15.2022
Five Deans Technology Showcases E-Cigarette Products at Dortmund Tobacco Exhibition
Five Deans showcased their e-cigarettes at the Dortmund Tobacco Exhibition, featuring colorful designs and large capacities.

On September 15th at 10:00 am local time (4:00 pm Beijing time), the Dortmund Tobacco Expo grandly opened at the Dortmund Exhibition Center, covering an area of over 40,000 square meters. As a well-known OEM/ODM enterprise in the industry, Wulian Technology, a subsidiary of listed company Five Rings Group, proudly showcased its full range of electronic cigarette products at booth 1.A28, including CBD products and disposable e-cigarette series.


Visitors to the tobacco exhibition in Dortmund, Germany, had the opportunity to experience five top-notch electronic cigarette products.


Nextvapor Wudian Technology focuses on trendy designs and colorful packaging, emphasizing the currently popular large capacity and wide-mouthed products. Its brand DUNKE offers disposable electronic cigarettes, pod vapes, and accessories, while the BTBE brand's ONX disposable CBD electronic cigarette has also gained popularity among exhibition attendees for its sleek design.


Wodian Technology's electronic cigarette product line.


Widely popular in the global market, Wodian Technology boasts a comprehensive line of disposable electronic cigarettes, ranging from 2ml to a massive 16ml capacity, complying with European standards. The products come in different shapes and an array of colors that attract the attention of onlookers. Additionally, their pod vape products have a capacity of up to 5ml, catering to current customers' preference for high-capacity products.


Visitors at the Dortmund Tobacco Expo in Germany had the opportunity to try out the product line of electronic cigarettes from Wodian Technology.


Wudian Technology focuses on the research and development, production, sales, and service of electronic cigarettes. The factory covers an area of over 30,000 square meters with a monthly production capacity of up to 2400K. Since its establishment in 2017, the company has grown rapidly and now owns brands such as Dunke, BTBE, and NEXTVAPOR. Its CBD business has particularly shown impressive growth and has reached the TOP3 ranking in the CBD industry in 2021.


Exhibition poster of Wu Dian.


To read more about the latest news and reports on the Dortmund tobacco exhibition in Germany, please click on the link below.


1. This article is intended solely for internal discussion and communication within the industry, and does not make any brand or product promotions or recommendations. 2. Smoking is detrimental to health. Minors are prohibited from reading this article.


This article is an original work of 2FIRSTS Technology Co., Ltd. in Shenzhen, and its copyright and permission for use belong to the company. No individual or organization is allowed to copy, reprint, or infringe upon the company's copyright without authorization. If anyone violates these terms, the company reserves the right to pursue legal action.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
Revised Tobacco Business Act to Take Effect in South Korea, Banning Online Sales of Liquid Vapes
Revised Tobacco Business Act to Take Effect in South Korea, Banning Online Sales of Liquid Vapes
South Korea’s Ministry of Health and Welfare will implement a partial revision of the Tobacco Business Act on April 24. The scope will expand from products made with “tobacco leaves” to all products manufactured with natural or synthetic nicotine. Synthetic nicotine liquid e-cigarettes, which had previously been treated as industrial products and were freely sold and advertised online, will from April 24 be subject to the same regulations as ordinary tobacco products.
Apr.23 by 2FIRSTS.ai
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
UK Tobacco and Vapes Bill Returns to House of Lords on April 20 for Ping Pong Consideration
UK Tobacco and Vapes Bill Returns to House of Lords on April 20 for Ping Pong Consideration
The UK Tobacco and Vapes Bill is set to return to the House of Lords on April 20 for consideration of Commons amendments in the parliamentary “ping pong” process. The bill aims to create the first “smoke-free generation” by ensuring that children turning 15 this year or younger can never legally be sold tobacco. It also seeks to enable product and information requirements to be imposed in connection with tobacco, vapes, and other products.
Apr.21 by 2FIRSTS.ai